13:30-13:50 | Keynote |
ML-assisted Design of Nanomedicine |
|
||||
13:50-14:10 | Keynote |
Virus-Mimetic Fusogenic Nanoparticles for Cell-Targeted Drug Delivery |
|
||||
14:10-14:25 | Invited |
Bioinspired mesoporous nanoparticles as targeted cancer theranostics |
|
||||
14:25-14:40 | Invited |
Rational Design and Practical Exploration of Oral Nano Drug Delivery Systems |
|
||||
14:40-14:50 | Oral Report |
Precision therapies for cancer via functionalized two-dimensional nanomedicine |
|
||||
14:50-15:00 | Oral Report |
Preliminary exploration of molecularly imprinted polymers for drug-resistant cancer therapy |
|
||||
15:00-15:10 | Oral Report |
Chiral Nanoparticle for Immunological Modulation |
|
||||
15:10-15:20 | Oral Report |
Dynamic Control of Liganded Nanogeometry for Cellular Regulation |
|
||||
15:20-15:30 | Oral Report |
Biological effects of interaction between nanomaterials and virus particles |
|
||||
15:30-15:45 | Other |
Coffee Break |
15:45-16:05 | Keynote |
Exosome based nanoplasmonic biosensors |
|
||||
16:05-16:25 | Keynote |
Dual-pathway STING Nanoagonist Amplifies DNA Sensing and Golgi Trafficking to Reprogram Immunosuppressive Microenvironment for Hepatocellular Carcinoma Therapy |
|
||||
16:25-16:45 | Keynote |
Application of Biomedical Materials in Disease Immunotherapy |
|
||||
16:45-17:00 | Invited |
Material and Bio-Interface Design with Biomimicry for Biomedical Applications |
|
||||
17:00-17:15 | Invited |
Polymeric vaccine carriers for subunit antigens |
|
||||
17:15-17:25 | Oral Report |
Targeted Delivery of Nanobodies for Intracellular Botulinum Toxin Therapy in Motor Neurons Based on DNA Origami Platform |
|
||||
17:25-17:35 | Oral Report |
Hafnium oxide-based sensitizer with radiation-triggered cuproptosis for radiotherapy |
|